Case Report: Addition of Naltrexone and Bupropion to Lorcaserin to Manage Olanzapine-induced Weight Gain

Journal Title: International Archives of Clinical Pharmacology - Year 2016, Vol 2, Issue 1

Abstract

Antipsychotic medications, both typical and atypical, share the potential side effect of weight gain with atypical agents carrying a greater risk. Atypical antipsychotics, such as clozapine and olanzapine, which antagonize the 5-hydroxytryptamine (serotonin) subtype 5-HT2C receptor, have been associated with a higher likelihood to induce weight gain.

Authors and Affiliations

Keywords

Related Articles

Novel Concepts for Clinical Pharmacology from "Calcium Paradox" due to Neuronal Interaction between Signalling Pathways Mediated by Ca2+ and cAMP: from 1975 to 2017

The solution for the so-called "calcium paradox" has been revealed 4 years ago, when we demonstrated the involvement of the interaction between Ca2+ and cAMP signalling pathways (Ca2+/cAMP signalling interaction) in this...

Mass Dose Effects of Carfentanil and Raclopride on Venous Plasma Cortisol and Prolactin after Tobacco Smoking during PET Scanning

Mass dose effects of the PET radioligands [11C] carfentanil and [11C] raclopride were determined on venous plasma cortisol and prolactin levels before and after tobacco smoking in overnight abstinent healthy male smokers...

Pharmaceutical Characterization and Detection Using Surface-Enhanced Raman Scattering

Surface-enhanced Raman scattering (SERS) is a surface sensitive method that results in the enhancement of Raman scattering by molecules adsorbed on rough metal surfaces. The enhancement factor can be as much as 107 -1015...

Prolonged Coagulopathy Following Rattlesnake Envenomation Responsive to Antivenom: A Case Report

Introduction Venom-specific immunoglobulin G fragments are used for the management of patients with North American crotalid envenomation. In this case, ongoing coagulopathy and clinically significant sequelae required a...

Case Report: Addition of Naltrexone and Bupropion to Lorcaserin to Manage Olanzapine-induced Weight Gain

Antipsychotic medications, both typical and atypical, share the potential side effect of weight gain with atypical agents carrying a greater risk. Atypical antipsychotics, such as clozapine and olanzapine, which antagoni...

Download PDF file
  • EP ID EP349266
  • DOI 10.23937/2572-3987.1510004
  • Views 97
  • Downloads 0

How To Cite

(2016). Case Report: Addition of Naltrexone and Bupropion to Lorcaserin to Manage Olanzapine-induced Weight Gain. International Archives of Clinical Pharmacology, 2(1), 1-2. https://europub.co.uk/articles/-A-349266